triazoles has been researched along with cenicriviroc in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertine, M; Brun-Vézinet, F; Charpentier, C; Collin, G; Damond, F; Descamps, D; Lefebvre, E; Matheron, S; Peytavin, G; Visseaux, B | 1 |
Giesler, KE; Kim, MB; Liotta, DC; Tahirovic, YA; Truax, VM; Wilson, LJ | 1 |
1 review(s) available for triazoles and cenicriviroc
Article | Year |
---|---|
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.
Topics: Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Design; HIV Infections; Humans; Imidazoles; Maraviroc; Sulfoxides; Triazoles | 2016 |
1 other study(ies) available for triazoles and cenicriviroc
Article | Year |
---|---|
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Coculture Techniques; Cyclohexanes; HIV Infections; HIV-2; Humans; Imidazoles; Leukocytes, Mononuclear; Maraviroc; Phenotype; Phytohemagglutinins; Receptors, CCR2; Receptors, CCR5; Sulfoxides; Triazoles; Virus Replication | 2015 |